Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Medtronic
Merck
McKesson
Cantor Fitzgerald
Teva
US Department of Justice
AstraZeneca
McKinsey

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,597,272

« Back to Dashboard

Which drugs does patent 8,597,272 protect, and when does it expire?

Patent 8,597,272 protects ZECUITY and is included in one NDA.

This patent has seventeen patent family members in eleven countries.
Summary for Patent: 8,597,272
Title:Pharmacokinetics of iontophoretic sumatriptan administration
Abstract: Improved pharmacokinetic profiles for the iontophoretic delivery of sumatriptan are described.
Inventor(s): Sebree; Terri B. (Gladwyne, PA), Pierce; Mark (Essex, CT), O'Neill; Carol (Phoenixville, PA)
Assignee: Nupathe, Inc. (Malvern, PA)
Application Number:13/407,434
Patent Claim Types:
see list of patent claims
Use; Formulation; Delivery;

Drugs Protected by US Patent 8,597,272

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Teva Branded Pharm ZECUITY sumatriptan succinate SYSTEM;IONTOPHORESIS 202278-001 Jan 17, 2013 DISCN Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,597,272

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,155,737 Pharmacokinetics of iontophoretic sumatriptan administration ➤ Sign Up
9,427,578 Pharmacokinetics of iontophoretic sumatriptan administration ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,597,272

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
New Zealand 590356 ➤ Sign Up
Japan 5951741 ➤ Sign Up
Japan 2015091821 ➤ Sign Up
Japan 5662312 ➤ Sign Up
Japan 2011524784 ➤ Sign Up
Israel 209756 ➤ Sign Up
Israel 238603 ➤ Sign Up
European Patent Office 2303392 ➤ Sign Up
Spain 2603274 ➤ Sign Up
Eurasian Patent Organization 025505 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Fish and Richardson
Harvard Business School
Express Scripts
Julphar
Daiichi Sankyo
Boehringer Ingelheim
Cipla
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot